Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Clinical practice of nebulized therapy in China: a national questionnaire survey.

Zhu Z, Zheng J, Wu Z, Xie Y, Gao Y, Zhong L, Jiang M.

J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):386-91. doi: 10.1089/jamp.2013.1053. Epub 2014 Jan 2.

PMID:
24383963
2.

Ipratropium treatment of acute airways disease.

Peterson GM, Boyles PJ, Bleasel MD, Vial JH.

Ann Pharmacother. 2003 Mar;37(3):339-44.

PMID:
12639159
3.

Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.

Nicolini G, Cremonesi G, Melani AS.

Pulm Pharmacol Ther. 2010 Jun;23(3):145-55. doi: 10.1016/j.pupt.2009.11.003. Epub 2009 Dec 2. Review.

PMID:
19961948
4.

The role of nebulized therapy in the management of COPD: evidence and recommendations.

Dhand R, Dolovich M, Chipps B, Myers TR, Restrepo R, Farrar JR.

COPD. 2012 Feb;9(1):58-72. doi: 10.3109/15412555.2011.630047. Review.

PMID:
22292598
5.

Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study.

Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, Yang CZ, Zhong N.

Respirology. 2013 Nov;18 Suppl 3:47-52. doi: 10.1111/resp.12168.

PMID:
24188203
6.

Bronchodilators use in patients with COPD.

Dong YH, Hsu CL, Li YY, Chang CH, Lai MS.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 1;10:1769-79. doi: 10.2147/COPD.S86198. eCollection 2015.

7.

Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.

Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B.

Pediatrics. 2003 Sep;112(3 Pt 1):e212-9.

PMID:
12949315
8.

Nebulized therapy. SEPAR year.

Olveira C, Muñoz A, Domenech A.

Arch Bronconeumol. 2014 Dec;50(12):535-45. doi: 10.1016/j.arbres.2014.05.003. Epub 2014 Jul 2. Review. English, Spanish.

9.
10.

Subglottic laryngitis--Changes in therapy approach over the past 20 years.

Penezić A, Ivkić M, Ivkić B, Baudoin T.

Auris Nasus Larynx. 2015 Oct;42(5):390-5. doi: 10.1016/j.anl.2015.03.004. Epub 2015 Apr 24.

PMID:
25921270
11.

Aerosol therapy during mechanical ventilation: an international survey.

Ehrmann S, Roche-Campo F, Sferrazza Papa GF, Isabey D, Brochard L, Apiou-Sbirlea G; REVA research network.

Intensive Care Med. 2013 Jun;39(6):1048-56. doi: 10.1007/s00134-013-2872-5. Epub 2013 Mar 23.

PMID:
23525741
12.

The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study.

Calışkaner AZ, Öztürk C, Ceylan E, Pekcan S, Yılmaz Ö, Öztürk S, Can C, Şener O, Yılmaz Turay Ü, Koç N, Ersoy R.

Tuberk Toraks. 2013;61(3):183-92.

13.

Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey.

Braido F, Baiardini I, Sumberesi M, Blasi F, Canonica GW.

Respir Res. 2013 Sep 22;14:94. doi: 10.1186/1465-9921-14-94.

14.

Changes in inhaler devices for asthma and COPD.

Capriotti T.

Medsurg Nurs. 2005 Jun;14(3):185-94. Review. No abstract available.

PMID:
16035636
15.

Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes.

Marcus P, Oppenheimer EA, Patel PA, Katz LM, Doyle JJ.

Ann Allergy Asthma Immunol. 2006 May;96(5):736-43.

PMID:
16729789
16.

Inhalatory therapy training: a priority challenge for the physician.

Melani AS.

Acta Biomed. 2007 Dec;78(3):233-45. Review.

PMID:
18330086
17.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

18.

Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals.

Hartert TV, Windom HH, Peebles RS Jr, Freidhoff LR, Togias A.

Am J Med. 1996 Apr;100(4):386-94.

PMID:
8610724
19.

A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.

Kokturk N, Turktas H, Kara P, Mullaoglu S, Yilmaz F, Karamercan A.

Pulm Pharmacol Ther. 2005;18(6):416-21.

PMID:
15953743
20.

[Recommendations for nebulizer therapy].

Diot P, Zarka V, Lemarié E.

Rev Mal Respir. 2002 Feb;19(1):87-9. French. No abstract available.

PMID:
17546818

Supplemental Content

Support Center